Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting TGF-β Mediated SMAD Signaling for the Prevention of Fibrosis
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-07-14
DOI
10.3389/fphar.2017.00461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BMP-9 interferes with liver regeneration and promotes liver fibrosis
- (2017) Katja Breitkopf-Heinlein et al. GUT
- Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis
- (2017) Gunilla Westergren-Thorsson et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes
- (2017) Jerry R. Mendell et al. MOLECULAR THERAPY
- Specific targeting of TGF-β family ligands demonstrates distinct roles in the regulation of muscle mass in health and disease
- (2017) Justin L. Chen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro
- (2016) José M. Muñoz-Félix et al. CELLULAR SIGNALLING
- Extracellular Regulation of Bone Morphogenetic Protein Activity by the Microfibril Component Fibrillin-1
- (2016) Alexander P. Wohl et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease
- (2016) Olga A. Agapova et al. KIDNEY INTERNATIONAL
- Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial
- (2016) Craig Campbell et al. MUSCLE & NERVE
- TGF-β: the master regulator of fibrosis
- (2016) Xiao-ming Meng et al. Nature Reviews Nephrology
- Myostatin induces interstitial fibrosis in the heart via TAK1 and p38
- (2015) Nadine Biesemann et al. CELL AND TISSUE RESEARCH
- The activin A antagonist follistatin inhibits cystic fibrosis-like lung inflammation and pathology
- (2015) Charles L Hardy et al. IMMUNOLOGY AND CELL BIOLOGY
- Development of Novel Activin-Targeted Therapeutics
- (2015) Justin L Chen et al. MOLECULAR THERAPY
- A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy
- (2015) Jerry R Mendell et al. MOLECULAR THERAPY
- TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25years of trials and tribulations?
- (2015) José M. Muñoz-Félix et al. PHARMACOLOGY & THERAPEUTICS
- Role of bone morphogenetic protein-7 in renal fibrosis
- (2015) Rui Xi Li et al. Frontiers in Physiology
- BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy
- (2014) Princess Urbina et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity
- (2014) Valentina Masola et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Enhanced Bioactive Myocardial Transforming Growth Factor-β in Advanced Human Heart Failure
- (2014) Shaukat Khan et al. CIRCULATION JOURNAL
- Myostatin Stimulates, Not Inihibits, C2C12 Myoblast Proliferation
- (2014) Buel D. Rodgers et al. ENDOCRINOLOGY
- Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
- (2014) Stephanie Arndt et al. GUT
- Potential Roles of BMP9 in Liver Fibrosis
- (2014) Jianjun Bi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The Role of TGF-β2 and Bone Morphogenetic Proteins in the Trabecular Meshwork and Glaucoma
- (2014) Robert J. Wordinger et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- Elevated expression of activins promotes muscle wasting and cachexia
- (2013) Justin L. Chen et al. FASEB JOURNAL
- BMP-7 counteracting TGF-beta1 activities in organ fibrosis
- (2013) Ralf Weiskirchen Frontiers in Bioscience-Landmark
- Activation of TGF-β1 Promoter by Hepatitis C Virus-Induced AP-1 and Sp1: Role of TGF-β1 in Hepatic Stellate Cell Activation and Invasion
- (2013) Lance D. Presser et al. PLoS One
- Bone morphogenetic protein-7 inhibits silica-induced pulmonary fibrosis in rats
- (2013) Gengxia Yang et al. TOXICOLOGY LETTERS
- Interleukin-6, its role in fibrosing conditions
- (2012) Steven O’Reilly et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Bone Morphogenetic Protein-4 Mediates Cardiac Hypertrophy, Apoptosis, and Fibrosis in Experimentally Pathological Cardiac Hypertrophy
- (2012) Bo Sun et al. HYPERTENSION
- A single ascending-dose study of muscle regulator ace-031 in healthy volunteers
- (2012) Kenneth M. Attie et al. MUSCLE & NERVE
- Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis
- (2012) Hikaru Sugimoto et al. NATURE MEDICINE
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- Pirfenidone treatment of idiopathic pulmonary fibrosis
- (2012) Arata Azuma Therapeutic Advances in Respiratory Disease
- Loss of Endogenous Bone Morphogenetic Protein-6 Aggravates Renal Fibrosis
- (2011) Amélie Dendooven et al. AMERICAN JOURNAL OF PATHOLOGY
- Prodomains regulate the synthesis, extracellular localisation and activity of TGF-β superfamily ligands
- (2011) Craig A. Harrison et al. GROWTH FACTORS
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Thrombospondin-1: Multiple Paths to Inflammation
- (2011) Zenaida Lopez-Dee et al. MEDIATORS OF INFLAMMATION
- Role of Glomerular Proteoglycans in IgA Nephropathy
- (2011) Kerstin Ebefors et al. PLoS One
- The Evaluation of Ectopic Bone Formation Induced by Delivery Systems for Bone Morphogenetic Protein-9 or Its Derived Peptide
- (2011) Eric Bergeron et al. TISSUE ENGINEERING PART A
- Increased expression of collagens, transforming growth factor-β1, and -β3 in gluteal muscle contracture
- (2010) Chen-Guang Zhao et al. BMC MUSCULOSKELETAL DISORDERS
- Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
- (2010) J. Li et al. DIABETES
- rAAV2-TGF-β3 Decreases Collagen Synthesis and Deposition in the Liver of Experimental Hepatic Fibrosis Rat
- (2010) Yi Zhang et al. DIGESTIVE DISEASES AND SCIENCES
- Integrin–TGF-β crosstalk in fibrosis, cancer and wound healing
- (2010) Coert Margadant et al. EMBO REPORTS
- BMP-7 as antagonist of organ fibrosis
- (2010) Ralf Weiskirchen Frontiers in Bioscience-Landmark
- Activin A Binds to Perlecan through Its Pro-region That Has Heparin/Heparan Sulfate Binding Activity
- (2010) Shaoliang Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4
- (2010) Dianhua Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- Recombinant Myostatin (GDF-8) Propeptide Enhances the Repair and Regeneration of Both Muscle and Bone in a Model of Deep Penetrant Musculoskeletal Injury
- (2010) Mark W. Hamrick et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Effects of myostatin deletion in aging mice
- (2009) Michael R. Morissette et al. AGING CELL
- Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy
- (2009) Diana Llopiz et al. INTERNATIONAL JOURNAL OF CANCER
- Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies
- (2009) Mark WJ Ferguson et al. LANCET
- Murine Preosteoblast Differentiation Induced by a Peptide Derived from Bone Morphogenetic Proteins-9
- (2009) Eric Bergeron et al. TISSUE ENGINEERING PART A
- A synthetic peptide from transforming growth factor- 1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats
- (2008) N. Hermida et al. CARDIOVASCULAR RESEARCH
- Bone Morphogenetic Protein-2 Antagonizes Renal Interstitial Fibrosis by Promoting Catabolism of Type I Transforming Growth Factor-β Receptors
- (2008) Yu-Lin Yang et al. ENDOCRINOLOGY
- Myostatin Propeptide Gene Delivery by Adeno-Associated Virus Serotype 8 Vectors Enhances Muscle Growth and Ameliorates Dystrophic Phenotypes in mdx Mice
- (2008) Chunping Qiao et al. HUMAN GENE THERAPY
- Smad and p38 MAP Kinase-mediated Signaling of Proteoglycan Synthesis in Vascular Smooth Muscle
- (2008) Harsha Dadlani et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myostatin Directly Regulates Skeletal Muscle Fibrosis
- (2008) Zhao Bo Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFβ3): from laboratory discovery to clinical pharmaceutical
- (2008) Nick L. Occleston et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies
- (2008) Yury Popov et al. JOURNAL OF HEPATOLOGY
- Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
- (2007) M. Petersen et al. KIDNEY INTERNATIONAL
- Expression and characterization of a human BMP-7 variant with improved biochemical properties
- (2007) Bethany Swencki-Underwood et al. PROTEIN EXPRESSION AND PURIFICATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started